top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Atherosclerosis : Technologies of Personalized Medicine
Atherosclerosis : Technologies of Personalized Medicine
Autore Ragino Yuliya I
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (150 p.)
Soggetto topico Medicine
Cardiovascular medicine
Soggetto non controllato metalloproteinases
calcification
atherosclerosis
multiplex assay
coronary heart disease
aspirin
resistance
non-sensitivity
antiplatelet
light transmission aggregometry
Plateletworks®
familial hypercholesterolemia
targeted sequencing technologies
multiplex ligation-dependent probe amplification
LDLR
APOB
ABCG5
APOC3
LPL
SREBF1
rare variants
coronary atherosclerosis
ischemic heart disease
saturated fatty acids
monounsaturated fatty acids
polyunsaturated fatty acids
oxidative stress
superoxide dismutase
catalase
glutathione peroxidase
cumulative LDL-C level
prognosis
DNA methylation
epigenetic age
myocardial infarction
acute coronary syndrome
population
nested case-control
HAPIEE project
HAPIEE study
atrial fibrillation
arterial hypertension
obesity
diabetes mellitus
aging
determinants
prevalence
Russian population cohort
Cox regression analysis
adiponectin
leptin
interleukin-6
epicardial adipose tissue
perivascular adipose tissue
circulating biochemical markers
coronary atherosclerosis presence and severity
integrated biomarker (i-BIO)
validation
visual markers
lipoprotein(a)
immune cells blood count
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Atherosclerosis
Record Nr. UNINA-9910566478403321
Ragino Yuliya I  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Ischemic Heart Disease in the Context of Different Comorbidities
Ischemic Heart Disease in the Context of Different Comorbidities
Autore Costache Irina-Iuliana
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (242 p.)
Soggetto topico Medicine
Cardiovascular medicine
Soggetto non controllato coronary artery disease
ischemic heart disease
atherosclerosis
genetic risk factors
heritability
polymorphism
GWAS
PRS
COVID-19
myocardial ischemia
electrocardiography
accelerated atherosclerosis
coronary spasm
coronary thrombosis
endothelial dysfunction
cancer
prevention
radiotherapy
chemotherapy
liver cirrhosis
prevalence
liver transplantation
treatment
myocardial injury
cytokines
biomarkers
heart failure
left ventricular remodeling
myocardial infarction
wall stress
inflammation
neurohormonal activation
inflammatory bowel disease
ulcerative colitis
Crohn's disease
cardiovascular risk
frailty
chronic coronary syndrome
elderly
acute coronary syndrome
carbon monoxide poisoning
severity of poisoning
cardiotoxicity
troponin
cardiac dysfunction
non-alcoholic fatty liver disease
liver-heart axis
ISBN 3-0365-5809-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910637784603321
Costache Irina-Iuliana  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges
Autore Bakillah Ahmed
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (116 p.)
Soggetto non controllato apolipoprotein
lipids
risk stratification
proprotein convertase subtilisin-kexin type 9 (PCSK9)
vaspin
sphingolipids
PCSK9
ceramides
atrial fibrillation
circular RNA
STEMI
cholesterol
lipoproteins
cardiovascular disease (CVD)
coronary artery bypass grafting
atherosclerosis
statin
LDL subfractions
acute kidney injury
dyslipidemia
gene expression
NSTEMI
NAFLD
hyperlipidemia
nonstatin
cholesteryl ester transfer protein
low-density lipoprotein cholesterol
anacetrapib
HDL
acute coronary syndrome
miRNA
cardiovascular risk
pleiotropic actions
genetic
ABCA1
sdLDL
cardiovascular disease
proprotein convertase subtilisin/kexin type 9
inclisiran
reverse cholesterol transport
sterol
small interfering RNA (siRNA)
RNA-binding proteins
cardiovascular diseases
NASH
low-density lipoprotein-cholesterol (LDL-C)
stroke
nutrigenetics
type 2 diabetes
statins
sphingomyelin
hepatic fibrosis
diabetes
ISBN 3-03921-677-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases
Record Nr. UNINA-9910367751903321
Bakillah Ahmed  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Technologies for the Treatment of Coronary and Structural Heart Diseases
New Technologies for the Treatment of Coronary and Structural Heart Diseases
Autore Polimeni Alberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (352 p.)
Soggetto topico Medicine
Soggetto non controllato left atrial appendage
WATCHMAN occlusive device
2D transesophageal echocardiography
3D transesophageal echocardiography
computerized tomography
atherosclerosis
cholesterol
FDG
inflammation
PET
statins
coronary artery bypass
on-pump coronary artery bypass
off-pump coronary artery bypass
young patients
severe aortic stenosis
longitudinal axis strain
late gadolinium enhancement
cardiac magnetic resonance imaging
optical coherence tomography
percutaneous coronary interventions
borderline lesions
nonsignificant lesions
left main
bifurcations
bilateral internal mammary artery
coronary artery disease
coronary artery bypass grafting
da Vinci
sternotomy
outcome
stent thrombosis
bioresorbable scaffold
drug eluting stents
stent bioresorbable
congenital heart disease
cardiac surgery
open heart
progenitor cells
regeneration
stem cells
subclinical coronary artery disease
accelerated atherosclerosis
HIV infection
carotid intima-media thickness
coronary calcium scoring
coronary CT angiography
magnetic resonance angiography
fluorodeoxyglucose positron emission tomography
mechanical circulatory support
percutaneous coronary intervention
cardiogenic shock
acute myocardial infarction
patient selection
right heart catheterization
pulmonary hypertension
heart failure
diagnosis
prognostic evaluation
clinical implications
systemic disease
cardiac computed tomography
cardiac magnetic resonance
feature tracking
tagging
myocardial deformation
strain
radial
ulnar
distal radial
snuffbox
aortic valvuloplasty
dual antiplatelet therapy
antiplatelet
structural heart disease
bioresorbable vascular scaffold
drug-eluting stent
angioplasty
acute coronary syndrome
chronic total occlusion
target vessel failure
re-occlusion
surveillance coronary angiography
meta-analysis
ACURATE neo
SAPIEN 3
transcatheter aortic valve replacement
TAVR
TAVI
low risk
STS
aortic stenosis
SAVR
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557107503321
Polimeni Alberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nutrition, Exercise, and End-of-Life Discussion in the Cardiovascular Field
Nutrition, Exercise, and End-of-Life Discussion in the Cardiovascular Field
Autore Fukumoto Yoshihiro
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (194 p.)
Soggetto topico Medicine
Pharmacology
Soggetto non controllato milk intake
mortality
stroke
Bayesian survival analysis
time-to-event data
JACC study
unhealthy eating habits
accumulation
obesity
central obesity
general Japanese population
atherosclerotic cardiovascular disease
polyunsaturated fatty acids
eicosapentaenoic acid
docosahexaenoic acid
arachidonic acid
descriptive study
heart failure
vitamin D
big data
heart failure with preserved ejection fraction
geriatric nutritional risk index
behavioral modification stages
nutrition counseling
patient education
acute coronary syndrome
healthy behaviors
diet
legumes
fish
red/processed meat
physical activity
anxiety
depression
season
calorie intake
hospitalization
malnutrition
D-dimer
intervention
elderly
cardiovascular mortality
selenium
coenzyme Q10
acylcarnitine
brain natriuretic peptide
cardiac function
cardiomyopathy
carnitine deficiency
CPT2
end-stage kidney disease
free fatty acid
hemodialysis
continuous glucose monitoring
glucose fluctuation
intracranial artery stenosis
mean amplitude of glycemic excursions
standard deviation
palliative care
end-of-life care discussion
advance care planning
food intake
artificial nutrition
onco-cardiology
nutrition status
cancer
acute myocardial infarction
plant-based dietary patterns
grains
nuts
fruits
vegetables
cardiovascular disease
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576885403321
Fukumoto Yoshihiro  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacogenetics to Avoid Adverse Drug Reactions
Pharmacogenetics to Avoid Adverse Drug Reactions
Autore López-Fernández Luis A
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (220 p.)
Soggetto topico Medicine
Soggetto non controllato 5-fluorouracil
capecitabine
fluoropyrimidine
thymidylate synthase
thymidylate synthase enhancer region
upstream stimulatory factor 1
adverse drug reactions
pharmacogenomics
epistasis
random forest
statin
cardiovascular disease
colorectal cancer
personalised medicine
toxicity
(es)citalopram
drug-gene-interaction
drug-drug-interaction
drug-drug-gene-interaction
the PharmLines initiative
antipsychotic agents
pharmacogenetics
cytochrome P-450 enzyme system
psychotic disorders
precision medicine
direct oral anticoagulants
clinical implementation
atorvastatin
SLCO1B1
HLA
cutaneous adverse drug reaction
SCAR
genetic polymorphism
antiepileptics
CYP450 enzymes
platelet reactivity
single-nucleotide variants
acute coronary syndrome
clopidogrel
genotype
allele
polymorphism
HLA B
CYP2C9*3
cutaneous adverse drug reactions (CADRs)
anti-epileptic drugs (AEDS)
phenytoin (PHT)
genetic risk factors
South India
India
cardiology
adverse events
guidelines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557610103321
López-Fernández Luis A  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui